dsm

DSM is active worldwide in life science products, performance materials, polymers and industrial chemicals. The group has annual sales of EUR 8 billion and employs about 22,000 people (year-end 2001) at more than 200 sites worldwide.
DSM ranks among the global leaders in many of its fields. The company's strategy is aimed at generating sales of approx. EUR 10 billion in 2005. At least 80% of these sales should be generated by specialties, i.e. advanced chemical and biotechnological products for the life science industry and performance materials.
As such, this strategy represents a continuation of the company's ongoing transformation and concentration on global leadership positions in high-added-value activities characterized by high growth and more stable profit levels.

DSM is a highly integrated group of companies that is active worldwide in the field of chemicals, life science products and plastics with:

$5.9 billion in sales
22,000 people
More than 200 sites around the globe

DSM's headquarters are in Heerlen, The Netherlands. DSM's activities are organized in business groups corresponding to three coherent product/market combinations:

Life Science Products
Performance Materials
Polymers & Industrial Chemicals

The company's principal products are:

intermediates and ingredients for the pharmaceutical and food industries
performance materials (like engineering plastics, resins and synthetic rubbers) for the automotive and electrical/electronics industries
polymers as well as industrial chemicals for a wide range of manufacturing industries

DSM is the global market leader for several products including:

enzyme technologies and products
anti-infectives
caprocalctam
melamine
EPDM rubber

DSM Hydrocarbons
... operates two steam crackers which mainly produce polymer raw materials. The most important of these are ethylene and propylene, which are supplied to other DSM business groups as feedstocks for the production of polyethylene, polypropylene, EPDM rubber and acrylonitrile.

The product range further includes butadiene, benzene, MTBE, gasoline components, raw materials for hydrocarbon resins, aromatics, carbon black oil and styrene.

At the core of the DSM Hydrocarbons division, is its pair of naptha steam crackers with a combined annual capacity of over one million tons of ethylene and approximately 470 thousand tons of propylene. Additionally, DSM Hydrocarbons operates several modern downstream plants for benzene, butadiene, gasolines and an integrated unit for MTBE, carbon-black feedstocks, solvents and C9 resinfeed.

DSM Polyethylenes
ranks among the leading producers of polyethylenes in Europe in terms of both market position and cost price.
DSM Polyethylenes produces a variety of polyethylenes using several technologies. These materials are mainly used in the packaging industry.

DSM Polypropylenes
...manufactures polypropylene as well as a wide range of compounds based on this polymer.

The business group has a total production capacity of 750,000 tpa (including DSM Polyolefine). The products are used in packaging (flexible and rigid), fibres, automotive parts (e.g. bumper systems), pipes and electrical and electronic (E&E) components and equipment.

The business group aims to expand its position as a leading polypropylene supplier. In Western Europe, DSM holds a market share of 11% in polypropylene.

In 1997, DSM established DSM Polyolefine in Gelsenkirchen and took over the polyethylene and polypropylene activities of Veba Oel. This represented the ideal platform for implementing the group’s polymer strategy.

DSM currently has a polypropylene capacity of 750,000 tpa divided over three plants (total capacity of 550,000 tpa) at the large, integrated DSM site at Geleen (The Netherlands) and one plant in Gelsenkirchen in Germany (DSM Polyolefine GmbH, the former Vestolen GmbH). By the year 2001, when a new plant in Gelsenkirchen comes on stream, capacity will amount to more than 1 million tpa.

Existing facilities with an annual capacity of approximately 300,000 metric tons of polyolefines are being modernized and expanded, and two modern new plants will boost production to almost a million metric tons per year by the year 2001 to triple present production with a workforce of 500.

DSM Hydrocarbons Americas, Inc.
is a sales office whose primary business focus is on the sales and procurement of products for DSM Hydrocarbons in The Netherlands.

DSM Hydrocarbons Americas’ geographical focus is the USA, Canada, Mexico, Venezuela and Colombia. For the Latin American market DSM Hydrocarbons Americas also sells caprolactam, cyclohexanone and specialty chemicals.

2003/2/11 DSM

Contract to sell Roche’s vitamins, carotenoids and fine chemicals business to DSM signed
　　　http://www5.dsm.com/en_US/html/media/press_releases/03-03-roche.htm

DSM and Roche announced today that the contract to acquire Roche’s vitamins, carotenoids and fine chemicals business has been signed. This transaction is subject to approval by the anti-trust authorities.

For Roche, this agreement allows to further focus our group on our two high-tech pillars, pharmaceuticals and diagnostics to further establish our position as a leading, innovation driven healthcare company.”

2003/2/21 Financial Times

DSM pays EUR 300 M less for Roche vitamins division.

DSM is to pay EUR 300 M less for Roche's vitamins division because the slowdown in economic growth has had an adverse effect on the vitamins market.

May 1, 2003 Dow Jones

EU Delays Decision On DSM's Purchase Of Roche Operations

　

2004/1/14　DSM

DSM、日本におけるロシュのビタミンおよびファインケミカルズ事業の統合を完了
ロシュ・ビタミン・ジャパン株式会社は、新社名「DSM ニュートリションジャパン株式会社」で、日本市場におけるさらなるビジネス展開を推進

オランダのスペシャリティ・ケミカル・カンパニーであるDSM N.V. (本社：オランダヘーレン市、会長：ピーター・エルバディング、以下 DSM）は、DSMによるロシュ社（スイス）のビタミンおよびファインケミカル事業の買収にともなう、日本における事業統合を正式に完了したことを、本日発表しました。

これにより、ロシュ・ビタミン・ジャパン株式会社（本社：東京都大田区、代表取締役社長：レオ・ダーム）は、2004年1月1日付けで「DSM ニュートリションジャパン株式会社」（DSM Nutrition Japan K.K.　以下 DSMニュートリションジャパン）に社名変更し、DSMの日本市場におけるライフサイエンス事業の中核を担う組織として、引き続き高品質な製品の開発と製造に努めてまいります。

2004/11/24 DSM

Royal DSM N.V. intends to participate in North China Pharmaceutical Group Corporation
http://www.dsm.com/en_US/html/media/press_releases/35_04_NCPC.htm

Today, Royal DSM N.V., headquartered in Heerlen, The Netherlands, confirmed that it is engaged in discussions with North China Pharmaceutical Group Corporation (“NCPC”) of Shijiazhuang石家庄, Hebei Province河北省, People’s Republic of China, regarding a strategic partnership via a.o. participation in the equity ownership of North China Pharmaceutical Company, Ltd. (“NCPC Ltd.”), a company which is listed on the Shanghai stock exchange. DSM’s equity participation in NCPC Ltd. is related to the establishment of joint ventures in the area of vitamins and anti-biotic products.

NCPC
NCPC, together with its affiliates, is one of the largest vitamins and antibiotics manufacturers in the People’s Republic of China, originally established in 1953 in Hebei Province. NCPC comprises 28 controlled subsidiaries, 12 associated companies, and an additional 20 indirectly controlled subsidiaries. Total 2003 group revenues of NCPC are approximately RMB 7 billion (EUR 700 million).

Platts 2005/8/19

DSM Nanjing to start expanded CPL plant, full rates end '05

DSM Nanjing Chemical Co is looking to start up its newly-expanded caprolactam plant in Nanjing, China in the first half of September, a company source said Friday.
The plant with its capacity now doubled to 140,000 mt/yr is currently in a pre-commissioning state, and on water runs to get the functions going, the source added. Operations will be stabilized initially at 70% of capacity, with the full start-up by the end of 2005.

China Chemical Reporter 2005/9/7

DSM Deretil Formed JV with Shangyu Yuntao Chemicals
http://www.ccr.com.cn/news_view.asp?ID=737

DSM Deretil, global leader in the field of development, production and sales of side chains for betalactamic antibiotics and the Chinese company Shangyu Yuntao Chemicals Company, announced that they have formed a Joint Venture for the production of DL Phenyl Glycine and D(-) Phenyl Glycine. DSM Deretil acquired 51% of the shares and obtained an option to acquire the remaining 49% to gain full ownership of the company within the next three years.

“With this joint venture we realize the opportunity to combine Deretil’s superior technology with the low cost infrastructure of a Chinese manufacturer. This enables us to further build on the value proposals we can make to our customers and supply them with the quality they need in the highly competitive anti-infective market”, concludes Lluis Franquesa, General Manager of DSM Deretil at the closing of the agreement.

DSM Deretil is part of DSM N.V. through its DSM Anti-Infectives Business Group. And Shangyu Yuntao Chemicals Company is a privately owned company located in Shangyu 上虞 of Zhejiang province浙江省 in eastern China, and was established in 2001. Shangyu Yuntao Chemicals produces DL Phenyl Glycine and D(-) Phenyl Glycine, has annual sales of around US$7.3 million.

DSM Deretil
http://www.dsm.com/en_US/html/deretil/Deretil_Home.htm

DSM Deretil is a business unit of DSM Anti-Infectives, one of the business groups of DSM. DSM is active worldwide in life science and nutritional products, performance materials and industrial chemicals.

We are a leading company in the field of the development, production and sales of side chains for betalactamic antibiotics. DSM Deretil has a worldwide presence, long experience in the market and a strong customer focus orientation.

Globalization is a must for the pharmaceutical industry and DSM Deretil is in the lead. For crucial subjects like research & development, information & communication technology , personnel training, production sites, production processes, international customers and logistics this is firmly addressed in DSM Deretil's management strategy.

DSM Anti-Infectives comprises DSM’s activities in the field of development, production and sale of raw materials, intermediates, and bulk actives for anti-infectives such as antibiotics (for combatting bacterial infections) and anti fungals (for combatting fungal infections).

2005/9/8 DSM

DSM opens R&D Center in China
http://www.dsm.com/en_US/html/media/press_releases/24_05_DSM_RD_China.htm

DSM, the world-leading supplier of life science and nutritional products, performance materials and industrial chemicals, today opened its first Research & Development (R&D) Center in China. The center is located in Shanghai.

The DSM R&D Center China will be the company's main R&D base in the country and will form a vital part of DSM's global R&D network. In addition to carrying out product and applications development work, the center will support DSM's businesses in several other ways: by tracking market trends, by proactively responding to the needs of customers, and through interaction with the external know-how infrastructure, such as partners in universities, scientific research institutes and industry. DSM Nutritional Products, DSM Food Specialties and DSM NeoResins will be the first three DSM businesses to operate facilities at this R&D Center.

DSM Nutritional Products, formerly Roche Vitamins and Fine Chemicals, is the world's leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetic industries.

DSM Food Specialties is a leading producer of specialty food and feed ingredients. The product portfolio includes enzymes, yeast extracts, natamycin, starter cultures and media, cheese and meat coatings, antibiotic residue tests and natural beta-carotene.

DSM NeoResins We offer waterborne technologies such as acrylic emulsions and polyurethane dispersions for application in water-based coatings and water-based printing inks.

2005/9/30 DSM

DSM sells styrene-butadiene rubber business to Lion Chemical Capital LLC
http://www.dsm.com/en_US/html/media/press_releases/26_05_SBR.htm

DSM and Lion Chemical Capital LLC today announce the agreement on the sale of the DSM business unit SBR (styrene-butadiene rubber) to Lion Chemical Capital LLC. The transaction will take the form of an asset deal.

The sale is a result of DSM’s corporate strategy, Vision 2005: Focus & Value, which has transformed the company into a specialty company focusing on life science products and performance materials over the last few years. As a consequence, the SBR business no longer fits into DSM's portfolio.

Lion Chemical Capital
In 2004, Lion acquired the largest independent rubber compounding business in North America from PolyOne Corporation. The business, Excel Polymers, has over USD 400 million in revenues and includes eight plants located in the US, Mexico, U.K. and China. Excel Polymers provides effective solutions to both high volume and the most challenging technical rubber applications. The businesses will be operated as independent operations.

RubberWorld 2005/11/3

Lion closes on DSM rubber business

Lion Chemical Capital, LLC, a private New York-based investment firm, has announced the closing sale on DSM Copolymer Styrene-Butadiene Rubber (SBR). The new company will be called Lion Copolymer, LLC and will continue to be headquartered in Baton Rouge, La. Terms of the transaction were not disclosed.

SBR is used primarily by tire manufacturers and makers of conveyor belts, hoses and gaskets.

With this sale, Lion Copolymers will be one of the largest SBR producers in the United States, with revenues exceeding $200 million.

2005/10/18 DSM

DSM acquires Chinese resins producer Syntech
http://www.dsm.com/en_US/html/media/press_releases/29_05_syntech.htm

Dutch specialty chemicals company Royal DSM N.V. today acquired Syntech, a producer and marketer of coating resins. Syntech has annual sales of around USD 30 million, generated with a broad portfolio of coating resins. The acquisition of Syntech further strengthens DSM's liquid coating resins portfolio and will enable DSM to further accelerate the expansion of its activities in the Chinese market.

Syntech's activities are concentrated at one location in Shunde (Guangdong province 広東省順徳). The site includes production facilities, self-owned R&D laboratories and a pilot plant for product development.

http://www.syntech.com.cn/en/company.asp

2006/4/18 DSM

DSM to double capacity for engineering plastics in China 　　　　江陰市
http://www.dsm.com/en_US/html/media/press_releases/dep_china.htm

Royal DSM N.V. today announces the opening of its new compounding site for engineering plastics at Jiangyin in the Jiangsu province of China on April 26, 2006. This project will double the total capacity for the product lines Stanyl(R) PA46, Akulon(R) PA6 and Arnite(R) PBT. These materials are used in manufacturing key molded components for the automotive, electrical and electronics, consumer and industrial segments.

2006/9/8 DSM

DSM to build two new engineering plastic plants at Chemelot site, Geleen (NL)

Royal DSM N.V. today announces that it has decided to construct two new manufacturing facilities at its Chemelot site in Geleen, the Netherlands. DSM is making these investments in response to excellent market growth for two of the company’s top specialty products, Stanyl(R) polyamide 46 and Stamylan(R) UH ultra-high molecular weight polyethylene, which is used among other things as a raw material for Dyneema(R) high strength fibers. The new Stanyl(R) plant and the new Stamylan(R) facility, which will each double existing production capacity, are scheduled to come on line in 2008. The total investment will be around EUR 100 million.

Stanyl
Stanyl, the highest performance polyamide in the world, is a unique, high-crystallinity material that exhibits exceptional heat resistance, stiffness and strength, chemical resistance and processability. In addition, it has a low coefficient of friction and resists creep and deformation. Automotive applications of Stanyl include chain tensioners, engine covers, gears, sensors and clutch rings. Electrical applications include connectors, circuit breaker housings, microswitches, electric motor parts, and a variety of components for consumer electronics. Consumer applications include muffler covers for gas operated tools, water kettle components including safety switches, and a variety of other hand and power tool components.

Stamylan UH
Stamylan UH is a very high molecular weight polyethylene that exhibits excellent toughness and resistance to abrasion, outstanding chemical resistance and good low friction, non-stick characteristics. It is widely used for wear-resistant components in industrial, bulk materials handling and sports equipment as well as in ultra-strong fibers.

Dyneema
Dyneema is a super strong polyethylene fiber that offers maximum strength combined with minimum weight. It is up to 15 times stronger than quality steel and up to 40% stronger than aramid fibers, both on a weight-for-weight basis. Dyneema is an important component in marine and offshore ropes, in cables and nets, in safety gloves for the metalworking industry and in fine yarns for applications in sporting goods and the medical sector. In addition, Dyneema is used in bullet resistant armor and clothing for police and military personnel.

DSM Engineering Plastics
DSM Engineering Plastics is a business group forming part of DSM’s Performance Materials cluster. DSM Engineering Plastics is a global supplier of Stanyl PA 46 and Akulon 6 and 66 polyamides, Arnitel TPE-E, Arnite PBT and PET polyesters, Xantar polycarbonate, Yparex extrudable adhesive resins, and Stamylan UH Ultra High Molecular Weight PE. These materials are used in technical components for electrical appliances, electronic equipment and cars, in barrier packaging films as well as in many mechanical and extrusion applications. The business group had annual sales of EUR 705 million in 2005. It employs 1400 people worldwide and has eight production locations in Europe, the USA and Asia. With StanylR, it is the global market leader in high heat polyamides.

2007/9/14 DSM 　　　　　　　　　　　　　　　　工場

DSM starts initiative to extend its material portfolio for the orthopedic industry

Royal DSM N.V. today announces the start of an initiative to enter the market of ultra high molecular weight polyethylene (UHMWPE) for use in total joint arthroplasty 関節形成 and other medical devices. In the coming years DSM Biomedical will make significant investments in a research and development program focused on UHMWPE grades with optimized material properties, specifically aimed at currently unmet clinical needs in this orthopedic 整形外科 segment. This strategic material development links on to DSM’s activities in the Biomedical Emerging Business Area, which is an important element of DSM’s strategy Vision 2010 - Building on Strengths.

超高分子量ポリエチレン(UHMWPE)は、その優れた耐磨耗性及び耐衝撃性や低摩擦係数の故に、膝関節や股関節の整形外科の移殖に適した材料とされてきた。

DSM is already active in the orthopedic market with Dyneema Purity®, a fiber technology which was developed specially to obtain the required highest levels of quality and purity in medical applications, such as orthopedic implants.

Although DSM currently already is one of the major suppliers of Ultra High Molecular Weight Polyethylene, supplied under the trade name Stamylan® UH, DSM’s UHMWPE is not applied in arthroplasty applications yet.

UHMWPE：超高強力ポリエチレン繊維「Dyneema」原料
　　Dyneema fibers are made using a DSM patented (1979) method called gel spinning.
　　A precisely heated gel of UHMWPE is processed by an extruder through a spinneret

Dyneema Purity® is a highly purified grade of Dyneema® developed specifically for use in medical applications where maximum strength and minimum weight are required. It is ideal for orthopedic implants, for example, as it allows smaller implants to be used, and is flexible and resistant to abrasion. Similarly, its strength can be used for surgical instruments for minimally invasive procedures.

Typical applications for Stamylan UH (supplied in the form of a powder)

Automotive industry: battery separators

Electrical: cable clamps, contact breakers and insulation components

Food and beverage industry: star wheels, sliding rails, scrolls and feed worms, guide and deflector rollers, chute tables

Pulp and paper industry: suction box covers, scraper blades, foil covers

Textile industry: pickers and buffers

Chemical industry: pumps, valves and seals

Leisure industry: sliding surfaces for skis and snowboards

General machinery: bearings, gears, rollers, chain guides and tensioners

Bulk materials handling mining and agriculture: linings for silos, hoppers, trucks and ships, industrial drains

Porous parts: dust collection filters, water purification, perfume absorption, sound reduction and fluidisation

Ultra strong PE fibers: cables, ropes, fishing lines, ballistic vests, lightweight composite armour for vehicles and helmets

Microporous film: Lithium-ion battery separators, micro-filtration, specialty fabrics and tape

2007/10/5 DSM

DSM to invest in caprolactam plant at Chemelot, Geleen, the Netherlands

Royal DSM N.V. has decided to invest in capacity expansion and modernization of the caprolactam plant at the Chemelot Industrial Park in Geleen (NL). The total investment costs amount to EUR 25 million. This investment will allow DSM to gradually expand the capacity of the plant according to market demands.

Caprolactam is the key raw material for Nylon-6, a highly versatile material that is used to make not only textile, carpet and technical fibres, but also engineering plastics and packaging films. Nylon-6 is found in numerous applications ranging from conveyor belts, parachutes and lingerie to automotive air-inlets and packaging for fresh food products.

DSM says its Fibre Intermediates subsidiary is the leading global supplier of caprolactam, the key raw material for nylon 6.
It has three operating companies with a combined annual capacity of more than 0·5 million tons in Europe, the Americas and Asia Pacific.

DSM Fiber Intermediates increased its production capacity by expanding the annual caprolactum capacity at the DSM Nanjing Chemical Corporation from 70,000 tons per year to 140,000 tons by the end of 2005.

2007/10/8 DSM　　　　　　　　　　　　　　　高強度ポリエチレン

DSM expands Dyneema® production in Greenville, USA 　　　高強度ポリエチレン

Royal DSM N.V. today announces that it will invest to expand Dyneema® UD (UniDirectional bullet resistant sheet) production by 25% in its Greenville, North Carolina (USA) manufacturing facility.

The investment is driven by the increasing demand for Dyneema® UD in the US market for personal and especially vehicle security and protection against terrorism. Production in Greenville has a strong focus on supplying the US army and law enforcement agencies. By adding extra capacity to its highly integrated Greenville site, DSM remains capable of meeting increasing demand for its products and highly committed to the long term development of the US market. The new line is expected to come on stream in mid 2008. This news also comes on the heels of the recent decision to invest in a new Technical Service center at DSM’s Stanley, NC (USA) facility.

“Investing in further growth of Dyneema® in the US is in line with the focus on our local, and faithful customers and fits perfectly with the recently announced acceleration of DSM’s strategy, Vision 2010 - Building on Strengths, in which market-driven growth and innovation is one of the key pillars,” comments Nico Gerardu, member of DSM’s Managing Board and responsible for the Performance Materials cluster. “DSM will continue to further expand its global capacity for Dyneema® fiber and UD materials to maintain its global market leadership position. To our customers this should provide another example of our commitment to be the world’s most reliable and capable quality supplier of HPPE products.”

About DSM Dyneema
DSM Dyneema is the inventor and manufacturer of Dyneema®, the world’s strongest fiber™. Dyneema® is an ultra strong polyethylene fiber that offers maximum strength combined with minimum weight. It is up to 15 times stronger than quality steel and up to 40% stronger than aramid fibers, both on weight for weight basis. Dyneema® floats on water and is extremely durable and resistant to moisture, UV light and chemicals. The applications are therefore more or less unlimited. Dyneema® is an important component in ropes, cables and nets in the fishing, shipping and offshore industries. Dyneema® is also used in safety gloves for the metalworking industry and in fine yarns for applications in sporting goods and the medical sector. In addition, Dyneema® is also used in bullet resistant armor and clothing for police and military personnel.

Dyneema® is produced in Heerlen (The Netherlands) and in Greenville, North Carolina (U.S.A.). DSM Dyneema is also a partner in a high modulus polyethylene (HMPE) manufacturing joint venture in Japan. Further information on DSM Dyneema is available at www.dyneema.com.

2007/11/6 DSM

DSM to increase engineering plastics compounding capacity in China by 50%

Royal DSM N.V. today announces that it will expand its engineering plastics compounding capacity at the site in Jiangyin 江陰(China). The investment will increase the capacity of the compounding plant by 50% and the added capacity will be operational towards the end of 2008. This comes as an enhancement to DSM’s existing capacity, which was doubled in 2006 with the opening of this new greenfield site.

DSM opened its greenfield compounding plant for engineering plastics in Jiangyin in 2006 and is currently building a world-scale polyamide 6 polymerization plant at the same site, which will start production in 2008. At the Jiangyin site DSM manufactures Stanyl®, a high performance polyamide (PA46), Akulon® PA6, Arnite® PBT and PET, and Arnitel® TPE, which it supplies to customers throughout Asia in the automotive, electrical/electronics and manufacturing industries. The Jiangyin site also houses a Research and Development Center for engineering plastics, from which DSM supports customer developments throughout the region.

2007/12/20 DSM

DSM invests in ‘green’ polymers from CO2

DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announced that it has made an investment in Novomer Inc. The companies also plan to sign a cooperation agreement. Financial details of the investment will not be disclosed.

Novomer is developing a technology platform to use carbon dioxide and other renewable materials to produce performance polymers, plastics and other chemicals. The company’s products combine environmental benefits with improved materials performance and can be used in a range of applications, from injection molded parts for electronics to paper coatings and medical implants.

2008/3/8 DSM

DSM to sell Special Products to Arsenal Capital as first divestment following accelerated Vision 2010

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, has reached an agreement in principle with Arsenal Capital Partners (United States) on the sale of DSM Special Products BV. It is the first divestment following the accelerated Vision 2010 strategy. The transaction is expected to close in early Q2 2008, subject to regulatory and legal approvals.

The sale is a result of the acceleration of DSM’s transformation into a Life Sciences and Materials Sciences company. As outlined in the strategic program Vision 2010 - Building on Strengths a number of businesses which do not fit in the strategy, including DSM Special Products, will be divested.

DSM Special Products is the producer of Purox, an ingredient used in food as well as in a range of industrial applications. It also produces an ingredient for VevoVitall®, a product for the animal health market that will remain with DSM Nutritional Products. The supply of this ingredient for VevoVitall® to DSM Nutritional Products will not be affected due to an existing long-term supply agreement. DSM Special Products employs 126 people in Rotterdam and Sittard (Netherlands). They will all transfer to the new owner.
　　　　　Benzoic Acid 安息香酸(Purox B), Sodium Benzoate (Purox S)

2008/3/5 DSM

DSM invests in development of bio-based materials in China

DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announced that it has participated in a USD 20 million financing round in Tianjin Green Bio-Science Co., Ltd (China). The proceeds will be used to build China’s largest manufacturing plant for Polyhydroxyalkanoates (PHA) in the Tianjin Economic Development Area (TEDA).

微生物産生ポリエステル（ポリヒドロキシアルカン酸 PHA) は、バイオマス由来の有機物をある種の微生物に与えることにより得られる脂肪族ポリエステル

The plant’s construction will commence in Q2 2008, and is expected to start production in early 2009. It will have an annual production capacity of 10,000 tons of PHA.

About Tianjin Green Bio-Science Co., Ltd.
Tianjin Green Biosciences Co., Ltd (TGBS), located in the High-Tech Park of Tianjin University in TEDA, Tianjin, is dedicated to developing and producing biodegradable polymers and products. Research demonstrates that the PHAs TGBS developed have excellent biodegradable, processing performance and biocompatibility. Due to its special properties, the PHA could be developed for use of high value added products including high strength fiber, pressure sensitive adhesive, aqueous adhesive, human tissue engineering product, etc., as well as applications in food and commodity packaging, with the potential to substitute 50% petroleum-based plastic in application.

2008/9/3 DSM

DSM inaugurates Akulon® PA6 polymer plant in China

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the inauguration of its new polymer plant in Jiangyin (Jiangsu province, China) 江蘇省江陰市. The plant produces high viscosity grades of Akulon® polyamide 6 (PA6) aimed at the fast growing high end food packaging market in Asia. Construction of the plant, which was announced in September 2006, involved several tens of millions of USD.

DSM Engineering Plastics
DSM Engineering Plastics is a Business Group in the Performance Materials cluster of DSM, with sales in 2007 of EUR 839 million and approximately 1,550 employees worldwide. It is one of the world's leading suppliers of engineering thermoplastics offering a broad portfolio of high performance products including Stanyl® high performance polyamide and Akulon® 6 and 66 polyamides, Arnitel® TPE-E, Arnite® PBT and PET polyesters, Xantar® polycarbonate, Yparex® extrudable adhesive resins. These materials are used in technical components for electrical appliances, electronic equipment and cars, in barrier packaging films as well as in many mechanical and extrusion applications. With Stanyl®, it is the global market leader in high heat polyamides.

2009/3/19 DSM

DSM and NCPC sign contracts to establish nutrition and anti-infectives joint ventures in China

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, North China Pharmaceutical Group Corporation Ltd. (NCPC GroupCo) of Shijiazhuang, Hebei Province, People’s Republic of China, NCPC ListCo, the listed affiliate of NCPC and the State-owned Assets Supervision and Administration Commission of the State Council (SASAC) of Hebei Province today announce that they have signed the contracts regarding investment by DSM in NCPC GroupCo and the establishment of three joint ventures in the areas of nutritional products and anti-infectives.

These contracts are the follow-up to the announcements made at the end of 2004 and the further detailing of the agreement in late 2005. DSM will make a strategic investment in NCPC by obtaining a minority share (9.77%) in NCPC GroupCo. Parties will establish one nutrition production joint venture (Vitamin C) and two anti-infectives抗感染薬 business joint ventures (anti-infectives active pharmaceutical ingredients and intermediates). In the two anti-infectives joint ventures DSM will have a 51% interest. In the Nutrition production joint venture, DSM will hold a minority share of 30%.

The total cash investment by DSM following completion, will amount to approximately USD 110 million. In addition, DSM will with this investment leverage its technology and management capabilities.

NCPC
North China Pharmaceutical Group Corporation (NCPC) is one of the largest vitamin and antibiotics manufacturers in People’s Republic of China. NCPC is originally started in 1953 in the Hebei Province and now has eight production technology platforms including microbian pharmaceutical, chemical synthesis pharmaceutical, biochemical pharmaceutical, modern biotech pharmaceutical, natural drug extraction, nutritional healthcare products, bio-energy and biochemicals. In 2007, NCPC achieved sales revenue of RMB 6.42 billion.

May 4, 2009 British Plastics & Rubber

Further investment by DSM as it waits to sell its rubber businesses

Capacity for Sarlink, the thermoplastic vulcanisate（架橋型エラストマー：TPV)　business which DSM currently has up for sale alongside its EPDM business, has been doubled with the official opening of a new production unit at Genk in Belgium.
According to Sarlink business unit director and president David Huizing: "The TPV market is growing at rates beyond GDP growth, and Sarlink is growing much faster than that." Production capacity fell below demand in 2007, and since then the business has invested steadily in new capacity and new capabilities. The new Genk plant is fully automated and doubles (undisclosed) global capacity ? Sarlink also has a plant in Leominster, Massachusetts in the USA.
It was in 2007 that DSM announced that its elastomers businesses were to be sold off as part of the group's Vision 2010 plan to convert from an industrial chemicals company to a specialist in life science technologies. Despite its plans to get rid of them, DSM is continuing to invest in the development of its elastomer businesses and as well as this expansion of Sarlink capacity, its has been putting money into a new breed of EPDM, its Keltan ACE - Advanced Catalyst Elastomer. ACE has a high VNB (5-vinyl-2-norbornene) content which gives the EPDM a greater affinity for peroxide and so improves the curing process and the quality of the final elastomer, or can lower the hydrocarbon content of the compound and so improve oil resistance. ACE was revealed in 2007 and the first grade has now gone into production at Geleen in the Netherlands. The Keltan DE 8270C grade is intended for peroxide curing applications where it can reduce the level of peroxide needed, lowering costs and improving resistance to ageing with lower levels of residual peroxide.

Sarlink
架硫ゴムと熱可塑性樹脂の特長を有するエラストマーです。射出、押出、プロー成形などさまざまな成形加工が行えます。広範囲の硬度のグレードがあり、お客様のニーズにお答えします。サーリンクはDSM社が製造し、東洋紡が販売しております。 ..

September 27, 2007

DSM plans elastomers sell-off

DSM is planning to dispose of its elastomers and thermosets businesses as part of an accelerated move into life sciences and performance materials. In a restatement today of its Vision 2010 strategy DSM outlined a plan to move 'non-core' businesses into separate units for divestment.
In a strategy not unlike that pursued by Bayer over the past five years DSM is positioning itself in the nutrition, pharmaceutical and performance materials businesses in sectors where it has market-leading positions, and where it can build on its strengths in chemistry, process technology, biotechnology and materials science.
'Those businesses which do not fit with the strategic thrust will be carved out and divested, during the course of the Vision 2010 period, to new owners for whom there is a stronger strategic fit and under whose ownership they can prosper further,' says the company in today's announcement.

Initially these businesses will be grouped in a new Base Chemicals & Materials cluster and include:
Melamine, urea, fertilisers and energy, currently within Industrial Chemicals and with around Eur 700 million sales in 2007;
elastomers, currently within Performance Materials and with some Eur 500 million sales this year;
special products (Nutrition, Eur 100 million);
and maleic anhydride and its derivatives (Pharma, Eur 75 million).

DSM Fibre Intermediates, currently within Industrial Chemicals and which provides backward integration for DSM Engineering Plastics, will join a new division Polymer Intermediates.

DSM's new structure from 2008 will be:
Life Sciences (nutrition and pharma),
Materials Sciences (performance materials and polymer intermediates), and
Base Chemicals & Materials.

The company says it expects its 'portfolio adjustments' to be completed during the course of the Vision 2010 programme. The aim is to derive 60 per cent of the company's total revenues from specialty businesses, remaining only in those businesses formerly within the Industrial Chemicals cluster where backward-integration provides a competitive advantage.
Alongside its planned divestments DSM will seek acquisitions in its core business areas to achieve external growth. Internally it expects to achieve an additional 1 billion in sales from innovation by 2010, and has raised its organic sales growth target to more than 5 per cent annually and increased its expectations from China by half to forecast sales in 2010 up from a $1 billion target to $1・5 billion.
Sale of its non-core businesses will give DSM a reduced presence at the Chemelot site at Geleen in the Netherlands and DSM says it will review its options how it can best support the further development of that site into a successful industrial park. In addition, it will continue to invest in its R & D campus infrastructure on the site.

2009/7/29

DSM to sell DSM Energy to TAQA

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that it has reached an agreement with TAQA Abu Dhabi National Energy Company PJSC for the sale of DSM Energie Holding B.V. (DSM Energy) for an enterprise value of EUR 285 million. The intended sale is expected to close in Q3 2009, subject to regulatory approvals and notifications.

The disposal consists of the participations which DSM has in oil and gas exploration and pipelines, including the 40% participation in Noordgastransport.

DSM expects to realize a book profit of approximately EUR 275 million after tax on the sale. This profit will be reported as an exceptional item in the income statement at closing. DSM Energy realized net sales of EUR 161 million in 2008.

Rolf-Dieter Schwalb, Chief Financial Officer of Royal DSM gave the following comment: “ The intended sale of the energy business is another important step in DSM’s accelerated transformation towards a Life Sciences and Materials Sciences company. As stated before, in such a company there is no place for participations in oil and gas exploration and pipelines. These participations have a much better strategic fit with TAQA. I would like to thank all DSM Energy employees for their continued support and substantial contribution.”
.

2009/7/29

DSM to sell urea-licensing business to Maire Tecnimont

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Maire Tecnimont S.p.A., a leading international engineering and construction group headquartered in Italy, announce today that they have reached an agreement for the sale of DSM’s urea-licensing subsidiary Stamicarbon B.V. to Maire Tecnimont for a total consideration of EUR 38 million on a cash and debt-free basis. The intended sale is expected to close by Q4 2009, subject to regulatory and other customary approvals and notifications.

Stamicarbon, founded in 1947, is the world market leader in licensing urea technology with over 250 licensed urea plants located in over eighty different countries and a leading market share in new capacity. Urea, mainly used as a fertilizer, is produced from ammonia and carbon dioxide. Stamicarbon realized net sales of EUR 57 million in 2008 and an operating profit of EUR 25 million. In 2008 Stamicarbon’s operating profit was exceptionally high as a result of a number of large contracts closed during the year. The average operating profit for Stamicarbon has been approximately EUR 10 million per year over the past four years.